Cohance Lifesciences Limited reports a change in its board or management
In short
Cohance Lifesciences Limited informed the exchange on August 22, 2026, about a change in its directors, key managerial personnel, senior management personnel, auditor, or registrar and transfer agent. No figures, breakdowns, scheme amounts, or other numerical details were given. In simple terms, the company is reporting a management or related administrative change to the stock exchange, but the notice does not say what specifically changed. No closing date, deadline, or validity period was stated.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.